Interpreting therapy escalation after discordant Clostridioides difficile testing in IBD
Inflammatory Bowel Diseases · 01.11.2026 · 32 (11) · 2246-2246
DOI: 10.1093/ibd/izag186 ↗Kurz gefasst
Editorial in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 23.09.2026. Verfasst von Longwei Qiu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Southwest Medical University, Luzhou, Sichuan, People's Republic of China. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
- Department of Traditional Chinese Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
ORCID-Profile: Chaochi Yue
Zitieren
APA
Qiu, L., Tang, J., & Yue, C. (2026). Interpreting therapy escalation after discordant Clostridioides difficile testing in IBD. Inflammatory Bowel Diseases, 32(11), 2246-2246. https://doi.org/10.1093/ibd/izag186
Vancouver
Qiu L, Tang J, Yue C. Interpreting therapy escalation after discordant Clostridioides difficile testing in IBD. Inflammatory Bowel Diseases. 2026;32(11):2246-2246. doi:10.1093/ibd/izag186
BibTeX
@article{Qiu2026,
author = {Qiu, Longwei and Tang, Junyi and Yue, Chaochi},
title = {Interpreting therapy escalation after discordant Clostridioides difficile testing in IBD},
journal = {Inflammatory Bowel Diseases},
year = {2026},
volume = {32},
number = {11},
pages = {2246--2246},
doi = {10.1093/ibd/izag186}
}
EUVIMED